Metabolic Diseases Archives - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

Loargys (Pegzilarginase) Wins FDA Nod for Ultrarare Metabolic Disorder After Earlier Setbacks

Ozempic Lawsuits Continue With Second US Mass Litigation Involving GLP-1 Drugs and Vision Loss

December 19, 2025

Retatrutide, Eli Lilly’s Next-Gen Obesity Drug, Beats Out Zepbound in Late-Stage Trial

December 17, 2025

Arrowhead Secures First Approval with FDA Nod For FCS Therapy Redemplo Amid Ionis Clash

November 25, 2025

Life Science Podcast

Advancing Innovations for Diabetes and Cardiovascular Disease with Lexicon Pharmaceuticals’ CEO Mike Exton — Episode 230

October 29, 2025

Sephience (Sepiapterin) for PKU in Children and Adults: New BH4 Precursor Wins FDA Nod

A Novel Approach to MASH Obesity Treatment: Weight Loss with Mitochondrial Science

Business & Finance News

Harliku, First Ever FDA‑Approved Treatment for Alkaptonuria (AKU), Launched in US by Cycle Pharmaceuticals

Harnessing the Body’s Natural Mechanisms: Aphaia Pharma’s Novel Approach to Metabolic Disease Treatment

Business & Finance News

Aardvark Therapeutics IPO Sets Sights on Satiating Hyperphagia and Extreme Hunger

February 21, 2025

Life Science Podcast

Non-Hormonal Innovations in Obesity and Diabetes Treatment ft. Aphaia Pharma’s Dr. Steffen-Sebastian Bolz

August 30, 2024